ScholarIQanswers from OpenAlex
Ohio State University Hospital
InstitutionResearch output, impact & collaborations
Ohio State University Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Ohio State University Hospital?
ScholarIQrecord summary
Ohio State University Hospital is a research organisation in Columbus, US. OpenAlex records 3,346 works and 214,460 citations for it. 762 researchers list it as their most recent affiliation.
How many works does Ohio State University Hospital have?
ScholarIQindexed works
Ohio State University Hospital has 3,346 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ohio State University Hospital have?
ScholarIQcitation count
Ohio State University Hospital has 214,460 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Ohio State University Hospital?
ScholarIQresearcher count
Ohio State University Hospital has 762 researchers in the ScholarIQ index.
What is the average h-index at Ohio State University Hospital?
ScholarIQavg h-index
Ohio State University Hospital has an average h-index of 106 in OpenAlex.
What is the ROR of Ohio State University Hospital?
ScholarIQror
The ROR for Ohio State University Hospital is on the source record.
What is the OpenAlex record for Ohio State University Hospital?
ScholarIQopenalex
The OpenAlex for Ohio State University Hospital is on the source record.
Who are the most-cited researchers behind Ohio State University Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Ohio State University Hospital?
ScholarIQmost cited works
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lópes, Elaine M. Hylek, Michael G. Hanna, Hussein R. Al‐Khalidi, Jack Ansell, Dan Atar, Álvaro Avezum, M. Cecilia Bahit, Rafael Díaz, J. Donald Easton, Justin A. Ezekowitz, Greg Flaker, David García, Margarida Geraldes, Bernard J. Gersh, Golitsyn Sp, Shinya Goto, Antonio G. Hermosillo, Stefan H. Hohnloser, John D. Horowitz, Puneet Mohan, Petr Janský, Basil S. Lewis, José López‐Sendón, Prem Pais, Alexander Parkhomenko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lópes, Gretchen Heizer, Ronald Aronson, Amit N. Vora, Tyler Massaro, Roxana Mehran, Shaun G. Goodman, Stephan Windecker, Harald Darius, Jia Li, О. В. Аверков, M. Cecilia Bahit, Otávio Berwanger, Andrzej Budaj, Ziad Hijazi, Alexander Parkhomenko, Peter Sinnaeve, Robert F. Storey, Hölger Thiele, Dragoş Vinereanu, Christopher B. Granger, John H. Alexander
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Michael Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, Hans J. Woerle, David Baanstra, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, for the CARMELINA Investigators
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander, Renato D. Lópes, Stefan James, Rakhi Kilaru, Yaohua He, Puneet Mohan, Deepak L. Bhatt, Shaun G. Goodman, Freek W.A. Verheugt, Marcus Flather, Kurt Huber, Danny Liaw, Steen Husted, José López‐Sendón, Raffaele De Caterina, Petr Janský, Harald Darius, Dragoş Vinereanu, Jan H. Cornel, Frank Cools, Dan Atar, José L. Leiva-Pons, Mátyás Keltai, Hisao Ogawa, Prem Pais, Alexander Parkhomenko, Witold Rużyłło, Rafael Díaz, Harvey D. White, Mikhail Ruda, Margarida Geraldes, Jack Lawrence, Robert A. Harrington, Lars Wallentin
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas, John H. Alexander, John Amerena, Michael G. Hanna, Mátyás Keltai, Fernando Laņas, Renato D. Lópes, José López‐Sendón, Christopher B. Granger, Lars Wallentin
How much of the research on Ohio State University Hospital is open access?
ScholarIQopen access share
83%OPEN ACCESS